FABP3 and acute coronary syndrome: FABP3 elevations have also been related to different cardiac pathologies, including several cardiomyopathies, acute coronary syndrome (ACS) and HF [19] and proposed as a silent biomarker for the progression of myocardial damage in subjects with insulin resistance [20].